Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 2
2012 1
2014 1
2015 3
2016 2
2017 7
2018 6
2020 6
2021 5
2022 15
2023 10
2024 16
2025 16
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study.
Ray KK, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Laufs U, Mostaza JM, Nanchen D, Bardet A, Lamparter M, Chhabra R, Soronen J, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL; SANTORINI Study Investigators. Ray KK, et al. Eur J Prev Cardiol. 2024 Nov 11;31(15):1792-1803. doi: 10.1093/eurjpc/zwae199. Eur J Prev Cardiol. 2024. PMID: 38861400 Free article.
METHODS AND RESULTS: Patients with high or very high cardiovascular (CV) risk were recruited across 14 European countries from March 2020 to February 2021, with 1-year prospective follow-up until May 2022. ...Nonetheless, most patients remained above goal; hence, strategie …
METHODS AND RESULTS: Patients with high or very high cardiovascular (CV) risk were recruited across 14 European countries from March …
Cardiovascular risk and psoriasis: a role in clinical cardiology?
Imbalzano E, Casale M, D'Angelo M, Mandraffino G, Giugno V, Di Bella G, Carerj S, Dattilo G. Imbalzano E, et al. Angiology. 2015 Feb;66(2):101-3. doi: 10.1177/0003319714527339. Epub 2014 Mar 25. Angiology. 2015. PMID: 24671131 Review. No abstract available.
Hypertriglyceridemia: Molecular and Genetic Landscapes.
Scicchitano P, Amati F, Ciccone MM, D'Ascenzi F, Imbalzano E, Liga R, Paolillo S, Pastore MC, Rinaldi A, Mattioli AV, Cameli M. Scicchitano P, et al. Among authors: imbalzano e. Int J Mol Sci. 2024 Jun 8;25(12):6364. doi: 10.3390/ijms25126364. Int J Mol Sci. 2024. PMID: 38928071 Free PMC article. Review.
Lipid disorders represent one of the most worrisome cardiovascular risk factors. The focus on the impact of lipids on cardiac and vascular health usually concerns low-density lipoprotein cholesterol, while the role of triglycerides (TGs) is given poor attention. The litera …
Lipid disorders represent one of the most worrisome cardiovascular risk factors. The focus on the impact of lipids on cardiac and vas …
Stress Echocardiography in Italian Echocardiographic Laboratories: A Survey of the Italian Society of Echocardiography and Cardiovascular Imaging.
Ciampi Q, Pepi M, Antonini-Canterin F, Barbieri A, Barchitta A, Faganello G, Miceli S, Parato VM, Tota A, Trocino G, Abbate M, Accadia M, Alemanni R, Angelini A, Anglano F, Anselmi M, Aquila I, Aramu S, Avogadri E, Azzaro G, Badano L, Balducci A, Ballocca F, Barbarossa A, Barbati G, Barletta V, Barone D, Becherini F, Benfari G, Beraldi M, Bergandi G, Bilardo G, Binno SM, Bolognesi M, Bongiovi S, Bragato RM, Braggion G, Brancaleoni R, Bursi F, Dessalvi CC, Cameli M, Canu A, Capitelli M, Capra ACM, Carbonara R, Carbone M, Carbonella M, Carrabba N, Casavecchia G, Casula M, Chesi E, Cicco S, Citro R, Cocchia R, Colombo BM, Colonna P, Conte M, Corrado G, Cortesi P, Cortigiani L, Costantino MF, Cozza F, Cucchini U, D'Angelo M, Da Ros S, D'Andrea F, D'Andrea A, D'Auria F, De Caridi G, De Feo S, De Matteis GM, De Vecchi S, Del Giudice C, Dell'Angela L, Paoli LD, Dentamaro I, Destefanis P, Di Bella G, Di Fulvio M, Di Gaetano R, Di Giannuario G, Di Gioia A, Di Martino LFM, Di Muro C, Di Nora C, Di Salvo G, Dodi C, Dogliani S, Donati F, Dottori M, Epifani G, Fabiani I, Ferrara F, Ferrara L, Ferrua S, Filice G, Fiorino M, Forno D, Garini A, Giarratana GA, Gigantino G, Giorgi M, Giubertoni E, … See abstract for full author list ➔ Ciampi Q, et al. Among authors: imbalzano e. J Cardiovasc Echogr. 2023 Jul-Sep;33(3):125-132. doi: 10.4103/jcecho.jcecho_48_23. Epub 2023 Nov 20. J Cardiovasc Echogr. 2023. PMID: 38161775 Free PMC article.
BACKGROUND: The Italian Society of Echography and Cardiovascular Imaging (SIECVI) conducted a national survey to understand the volumes of activity, modalities and stressors used during stress echocardiography (SE) in Italy. ...
BACKGROUND: The Italian Society of Echography and Cardiovascular Imaging (SIECVI) conducted a national survey to understand the volum …
Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes.
Beer BN, Benson L, Basile C, Schrage B, Becher PM, Blankenberg S, Kirchhof P, Szabó-Söderberg B, Metra M, Lindberg A, Imbalzano E, Rosano GMC, Karlström P, Mol PGM, Scorza R, Lund LH, Lindberg F, Savarese G. Beer BN, et al. Among authors: imbalzano e. Eur J Heart Fail. 2025 Dec;27(12):2858-2868. doi: 10.1002/ejhf.70046. Epub 2025 Sep 11. Eur J Heart Fail. 2025. PMID: 40932340 Free PMC article.
Overlap-weighted models were used to assess associations between beta-blocker use and 5-year risk of outcomes, with cardiovascular death/total hospitalizations for HF (HHF) representing the primary cardiovascular effectiveness outcome, and total severe COPD exacerba …
Overlap-weighted models were used to assess associations between beta-blocker use and 5-year risk of outcomes, with cardiovascular de …
Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease.
Aragona CO, Imbalzano E, Mamone F, Cairo V, Lo Gullo A, D'Ascola A, Sardo MA, Scuruchi M, Basile G, Saitta A, Mandraffino G. Aragona CO, et al. Among authors: imbalzano e. Stem Cells Int. 2016;2016:8043792. doi: 10.1155/2016/8043792. Epub 2015 Dec 29. Stem Cells Int. 2016. PMID: 26839569 Free PMC article. Review.
To identify, evaluate, and synthesize evidence on the predictive power of circulating endothelial progenitor cells (EPCs) in cardiovascular disease, through a systematic review of quantitative studies. Data Sources. ...EPCs showed an important role in identifying cardio …
To identify, evaluate, and synthesize evidence on the predictive power of circulating endothelial progenitor cells (EPCs) in cardiovascul …
Psoriasis and Cardiovascular Risk: Correlation Between Psoriasis and Cardiovascular Functional Indices.
Dattilo G, Imbalzano E, Casale M, Guarneri C, Borgia F, Mondello S, Laganà P, Romano P, Oreto G, Cannavò S. Dattilo G, et al. Among authors: imbalzano e. Angiology. 2018 Jan;69(1):31-37. doi: 10.1177/0003319717699329. Epub 2017 Mar 21. Angiology. 2018. PMID: 29212353
Evidence suggests that psoriasis together with other cardiovascular (CV) risk factors is associated with increased vascular morbidity, but it is not clear whether psoriasis is an independent risk factor. ...
Evidence suggests that psoriasis together with other cardiovascular (CV) risk factors is associated with increased vascular morbidity …
Telemedicine and Digital Medicine in the Clinical Management of Hypertension and Hypertension-Related Cardiovascular Diseases: A Position Paper of the Italian Society of Arterial Hypertension (SIIA).
Minuz P, Albini FL, Imbalzano E, Izzo R, Masi S, Pengo MF, Pucci G, Scalise F, Salvetti M, Tocci G, Cicero A, Iaccarino G, Savoia C, Sechi L, Parati G, Borghi C, Volpe M, Ferri C, Grassi G, Muiesan ML; Italian Society of Arterial Hypertension (SIIA). Minuz P, et al. Among authors: imbalzano e. High Blood Press Cardiovasc Prev. 2023 Sep;30(5):387-399. doi: 10.1007/s40292-023-00595-0. Epub 2023 Aug 18. High Blood Press Cardiovasc Prev. 2023. PMID: 37594686 Free PMC article.
High blood pressure is the leading cause of death and disability globally and an important treatable risk factor for cardiovascular, cerebrovascular and chronic kidney diseases. Digital technology, including mobile health solutions and digital therapy, is expanding rapidly …
High blood pressure is the leading cause of death and disability globally and an important treatable risk factor for cardiovascular, …
RNA-targeted therapeutics in arterial hypertension.
Imbalzano E, Inciardi RM, Orlando L, Amati F, D'Ascenzi F, Liga R, Mattioli AV, De Fazio MG, Pastore MC, Rinaldi A, Scicchitano P, Cameli M. Imbalzano E, et al. Eur Heart J Qual Care Clin Outcomes. 2026 Apr 29;12(3):358-365. doi: 10.1093/ehjqcco/qcaf127. Eur Heart J Qual Care Clin Outcomes. 2026. PMID: 41122024 Review.
However, these therapies are not suitable for the acute management of hypertensive emergencies or urgencies, and evidence regarding their effects on cardiovascular outcomes, target organ protection, and mortality is still lacking. Further studies are warranted to define th …
However, these therapies are not suitable for the acute management of hypertensive emergencies or urgencies, and evidence regarding their ef …
The efficacy of PCSK9 inhibitors on major cardiovascular events and lipid profile in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials.
Imbalzano E, Ilardi F, Orlando L, Pintaudi B, Savarese G, Rosano G. Imbalzano E, et al. Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):318-327. doi: 10.1093/ehjcvp/pvad019. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36972610 Free article.
OBJECTIVE: To evaluate the specific effects of PCSK9 inhibitors (i.e. alirocumab and evolocumab) on major cardiovascular events (MACE) and lipid profile in patients with diabetes. METHODS AND RESULTS: We conducted a systematic review of literature according to the PRISMA s …
OBJECTIVE: To evaluate the specific effects of PCSK9 inhibitors (i.e. alirocumab and evolocumab) on major cardiovascular events (MACE …
88 results